Related Experiment Video

Updated: Aug 30, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.3K

Researchers tackle vexing side effects of potent cancer drugs

Jennifer Couzin-Frankel

    Science (New York, N.Y.)
    |September 1, 2022
    PubMed

    Insights

    Checkpoint inhibitor therapy is increasingly used, driving research into predicting and managing immune complications. Understanding these immune-related adverse events is crucial for patient safety and treatment efficacy.

    Area of Science:

    • Immunology
    • Oncology
    • Pharmacology

    Background:

    • Checkpoint inhibitor therapy has revolutionized cancer treatment.
    • Increased utilization necessitates proactive management of immune-related adverse events (irAEs).
    • Predictive biomarkers and therapeutic strategies for irAEs are under active investigation.

    Discussion:

    • Immune complications, or irAEs, arise from the dysregulation of the immune system by checkpoint inhibitors.
    • These irAEs can affect various organ systems, leading to significant morbidity.
    • Early identification and intervention are key to mitigating irAE severity.

    Key Insights:

    • Predicting irAEs remains a challenge, highlighting the need for novel biomarkers.
    • Current treatment strategies for irAEs involve immunosuppressive agents.
    • Tailoring treatment based on irAE type and severity is essential.

    Outlook:

    • Future research will focus on developing personalized approaches to irAE management.
    • Investigating the long-term effects of irAEs and their impact on cancer outcomes is important.
    • Advancements in understanding immune system modulation will refine checkpoint inhibitor therapy.

    More Related Videos

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

    Published on: February 6, 2015

    8.8K
    Assessing Specificity of Anticancer Drugs In Vitro09:39

    Assessing Specificity of Anticancer Drugs In Vitro

    Published on: March 23, 2016

    9.5K

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    7.9K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.8K
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.4K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    5.1K
    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    432
    Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

    Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

    Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
    Two synthetic agonists of THC,...
    362